Cargando…

T46. TARGETING THE IMMUNE SYSTEM TO TREAT DEPRESSION AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIA

BACKGROUND: Negative symptoms consist of impaired quality of life, social isolation, reduced emotional responsiveness, self-neglect and anhedonia, which have been categorised into avolition-apathy and expressive deficits sub-domains. The treatment of negative symptoms remains a challenge. Depression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krynicki, Carl, Upthegrove, Rachel, Suckling, John, Dazzan, Paola, Joyce, Eileen, Lawrie, Stephen, Husain, Nusrat, Chaudhry, Imran, Dunn, Graham, Jones, Peter, Lisiecka, Danuta, Lewis, Shon, Barnes, Thomas, Williams, Stephen, Hopkins, Stephen, Drake, Richard, Smallman, Richard, Giordano, Annalisa, Pariante, Carmine, Deakin, Bill
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888280/ http://dx.doi.org/10.1093/schbul/sby016.322

Ejemplares similares

T86. COGNITIVE SUBTYPES IN FIRST-EPISODE PSYCHOSIS: AN EMPIRICAL LONGITUDINAL STUDY OF RELATIONSHIP TO COGNITIVE, SYMPTOM AND FUNCTIONAL OUTCOMES
por: Watson, Andrew, et al.
Publicado: (2018)

The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial
por: Deakin, Bill, et al.
Publicado: (2018)

Cognitive function in early-phase schizophrenia-spectrum disorder: IQ subtypes, brain volume and immune markers
por: Watson, Andrew J., et al.
Publicado: (2023)

The benefit of minocycline on negative symptoms in early-phase psychosis in addition to standard care - extent and mechanism (BeneMin): study protocol for a randomised controlled trial
por: Lisiecka, Danuta M, et al.
Publicado: (2015)

Network analysis of inflammation and symptoms in recent onset schizophrenia and the influence of minocycline during a clinical trial
por: Herniman, Sarah E., et al.
Publicado: (2023)

30.1 IMMUNE PATHOGENESIS OF PSYCHOSIS: THE CHALLENGE OF CO-MORBIDITY
por: Upthegrove, Rachel, et al.
Publicado: (2018)

Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): study protocol for a randomised controlled feasibility study
por: Qurashi, Inti, et al.
Publicado: (2016)

Ondansetron and simvastatin added to treatment as usual in patients with schizophrenia: study protocol for a randomized controlled trial
por: Chaudhry, Imran B, et al.
Publicado: (2013)

Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): a feasibility study
por: Qurashi, Inti, et al.
Publicado: (2019)

Peripheral immune markers and antipsychotic non-response in psychosis
por: Enache, Daniela, et al.
Publicado: (2021)

T14. ASSESSING DIFFERENCES IN INFLAMMATORY MARKERS BETWEEN FIRST EPISODE PSYCHOSIS PATIENTS AND HEALTHY CONTROLS: THE IMPORTANCE OF CONTROLLING FOR CONFOUNDING FACTORS
por: Giordano, Annalisa, et al.
Publicado: (2018)

The Role of Peripheral Inflammation in Clinical Outcome and Brain Imaging Abnormalities in Psychosis: A Systematic Review
por: Kose, Melisa, et al.
Publicado: (2021)

Assessment of the impact of the scanner-related factors on brain morphometry analysis with Brainvisa
por: Shokouhi, Mahsa, et al.
Publicado: (2011)

Neuroinflammation as measured by positron emission tomography in patients with recent onset and established schizophrenia: implications for immune pathogenesis
por: Conen, Silke, et al.
Publicado: (2020)

Health beliefs and carer burden in first episode psychosis
por: Patel, Maya, et al.
Publicado: (2014)

Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study
por: Millgate, Edward, et al.
Publicado: (2021)

A Systematic Review of Cognitive Function in First-Episode Psychosis, Including a Discussion on Childhood Trauma, Stress, and Inflammation
por: Aas, Monica, et al.
Publicado: (2014)

Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders: A Mendelian Randomization Study
por: Williams, John A., et al.
Publicado: (2022)

Impaired verbal memory function is related to anterior cingulate glutamate levels in schizophrenia: findings from the STRATA study
por: Griffiths, Kira, et al.
Publicado: (2022)

An acute in-patient psychiatric service for 16- to 17-year-old adolescents in the UK: a descriptive evaluation
por: Duddu, Venu, et al.
Publicado: (2016)

Self-guided Cognitive Behavioral Therapy Apps for Depression: Systematic Assessment of Features, Functionality, and Congruence With Evidence
por: Martinengo, Laura, et al.
Publicado: (2021)

Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial
por: Husain, Muhammad I., et al.
Publicado: (2015)

A randomised double-blind placebo-controlled 12- week feasibility trial of methotrexate added to treatment as usual in early schizophrenia: study protocol for a randomised controlled trial
por: Chaudhry, Imran B, et al.
Publicado: (2015)

Molecular basis of surface anchored protein A deficiency in the Staphylococcus aureus strain Wood 46
por: Balachandran, Manasi, et al.
Publicado: (2017)

Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial
por: Husain, Muhammad I, et al.
Publicado: (2016)

Validity of subjective versus objective quality of life assessment in people with schizophrenia
por: Hayhurst, Karen P, et al.
Publicado: (2014)

Exercise as a protective mechanism against the negative effects of oxidative stress in first-episode psychosis: a biomarker-led study
por: Fisher, Emily, et al.
Publicado: (2020)

Inflammation in first‐episode psychosis: The contribution of inflammatory biomarkers to the emergence of negative symptoms, a systematic review and meta‐analysis
por: Dunleavy, Connor, et al.
Publicado: (2022)

Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis
por: Mondelli, Valeria, et al.
Publicado: (2015)

Research Evaluating Sports ConcUssion Events—Rapid Assessment of Concussion and Evidence for Return (RESCUE-RACER): a two-year longitudinal observational study of concussion in motorsport
por: Deakin, Naomi D, et al.
Publicado: (2021)

A word from the ISPNE President
por: Pariante, Carmine M.
Publicado: (2020)

O8.7. COGNITIVE SUBTYPES IN FIRST-EPISODE PSYCHOSIS AND ASSOCIATION TO TREATMENT RESPONSE
por: Russo, Manuela, et al.
Publicado: (2018)

Mental health services in Libya
por: Rhouma, Abdul Hakim, et al.
Publicado: (2016)

Protocol for the Psychosis Immune Mechanism Stratified Medicine (PIMS) trial: a randomised double-blind placebo-controlled trial of single-dose tocilizumab in patients with psychosis
por: Foley, Éimear M, et al.
Publicado: (2023)

Complete Genome Sequence of Staphylococcus aureus Strain Wood 46
por: Balachandran, Manasi, et al.
Publicado: (2017)

Prevention of: self harm in British South Asian women: study protocol of an exploratory RCT of culturally adapted manual assisted Problem Solving Training (C- MAP)
por: Husain, Nusrat, et al.
Publicado: (2011)

2-Methyl-4,6-bis(1-methylhydrazino)pyrimidine
por: Hutchinson, Daniel J., et al.
Publicado: (2009)

Globally Efficient Brain Organization and Treatment Response in Psychosis: A Connectomic Study of Gyrification
por: Palaniyappan, Lena, et al.
Publicado: (2016)

Quantification of glutathione in the human brain by MR spectroscopy at 3 Tesla: Comparison of PRESS and MEGA‐PRESS
por: Sanaei Nezhad, Faezeh, et al.
Publicado: (2016)

Effect of delaying treatment of first-episode psychosis on symptoms and social outcomes: a longitudinal analysis and modelling study
por: Drake, Richard J, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_imd31ernkf5gru65lbj7afflp4